Literature DB >> 20299283

Depression in advanced cancer.

Greg Irving1, Mari Lloyd-Williams.   

Abstract

PURPOSE: Depression is one of the most common psychiatric diseases seen in patients with advanced cancer. It is not only an independent predictor of poor survival in advanced cancer but also reduces quality of life, reduces compliance with treatment and prolongs hospitalization. Yet all too often depression is under diagnosed and under treated in this population.
METHOD: A literature review was undertaken using extensive electronic and hand searches. KEY
FINDINGS: Whilst it is true that the diagnostic and treatment challenges facing healthcare professionals in this area are considerable one must not forget that depression in advanced cancer is treatable and validated assessment tools have been developed to facilitate diagnosis.
CONCLUSIONS: This review article provides the reader with a comprehensive review of the current evidence in this field with particular focus on assessment and treatment. Depression is under diagnosed and under treated - there are valid screening and assessment tools available which will allow appropriate management of this important and debilitating symptom.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299283     DOI: 10.1016/j.ejon.2010.01.026

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  8 in total

1.  How family physicians address diagnosis and management of depression in palliative care patients.

Authors:  Franca Warmenhoven; Eric van Rijswijk; Elise van Hoogstraten; Karel van Spaendonck; Peter Lucassen; Judith Prins; Kris Vissers; Chris van Weel
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

2.  Pre-existing and new-onset depression among patients undergoing esophageal cancer surgery: a nationwide cohort study in South Korea.

Authors:  Tak Kyu Oh; In-Ae Song; Hye Yoon Park; Jung-Won Hwang
Journal:  Esophagus       Date:  2022-07-29       Impact factor: 3.671

3.  Effects of Dexamethasone and Placebo on Symptom Clusters in Advanced Cancer Patients: A Preliminary Report.

Authors:  Sriram Yennurajalingam; Janet L Williams; Gary Chisholm; Eduardo Bruera
Journal:  Oncologist       Date:  2016-02-17

4.  Depressive disorder in the last phase of life in patients with cardiovascular disease, cancer, and COPD: data from a 20-year follow-up period in general practice.

Authors:  Franca Warmenhoven; Hans Bor; Peter Lucassen; Kris Vissers; Chris van Weel; Judith Prins; Henk Schers
Journal:  Br J Gen Pract       Date:  2013-05       Impact factor: 5.386

5.  Protocol for a longitudinal qualitative interview study: maintaining psychological well-being in advanced cancer--what can we learn from patients' and carers' own coping strategies?

Authors:  Diane Roberts; Lynda Appleton; Lynn Calman; Paul Large; Gunn Grande; Mari Lloyd-Williams; Catherine Walshe
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

6.  Prevalence and risk factors of depressive symptoms in a Canadian palliative home care population: a cross-sectional study.

Authors:  Kathryn A Fisher; Hsien Seow; Kevin Brazil; Shannon Freeman; Trevor Frise Smith; Dawn M Guthrie
Journal:  BMC Palliat Care       Date:  2014-03-17       Impact factor: 3.234

7.  Depression Treatment in Individuals with Cancer: A Comparative Analysis with Cardio-Metabolic Conditions.

Authors:  Pallavi B Rane; Usha Sambamoorthi; Suresh Madhavan
Journal:  Health Psychol Res       Date:  2013-01-30

8.  p38 predicts depression and poor outcome in esophageal cancer.

Authors:  Yao Cheng; Zhe Qiao; Chengxue Dang; Bin Zhou; Shaomin Li; Wei Zhang; Jiantao Jiang; Yongchun Song; Jin Zhang; Dongmei Diao
Journal:  Oncol Lett       Date:  2017-10-03       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.